CD8A and rheumatoid arthritis: Altogether, these results demonstrate that the impaired p-mTOR activity, reduced glycolytic reliance, and defective protein synthesis observed in vitro are recapitulated in RA patients treated with JAKis, reinforcing the concept that memory CD8 T cells are direct targets of JAK-imediated metabolic rewiring.